GP6 and neoplasm: Tumor cell-expressed galectin-3 binds to platelet GPVI dimers, activates platelets, and forms a protective aggregation barrier around circulating tumor cells, protecting them from immune destruction.357,358 This phenomenon is known as tumor cell-induced platelet aggregation (TCIPA).